Prelude Capital Management’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $288K | Buy |
+976
| New | +$290K | 0.02% | 726 |
|
|
2025
Q3 | – | Sell |
-1,277
| Closed | -$352K | – | 1176 |
|
|
2025
Q2 | $352K | Sell |
1,277
-358
| -22% | -$97.4K | 0.03% | 553 |
|
|
2025
Q1 | $434K | Buy |
1,635
+46
| +3% | +$11.3K | 0.03% | 561 |
|
|
2024
Q4 | $369K | Buy |
+1,589
| New | +$365K | 0.02% | 710 |
|
|
2022
Q3 | – | Sell |
-2,178
| Closed | -$446K | – | 1619 |
|
|
2022
Q2 | $446K | Buy |
+2,178
| New | +$462K | 0.01% | 864 |
|
|
2022
Q1 | – | Sell |
-10,344
| Closed | -$2.36M | – | 1881 |
|
|
2021
Q4 | $2.36M | Sell |
10,344
-875
| -8% | -$193K | 0.06% | 263 |
|
|
2021
Q3 | $2.17M | Sell |
11,219
-6,390
| -36% | -$1.29M | 0.06% | 274 |
|
|
2021
Q2 | $3.75M | Buy |
17,609
+12,273
| +230% | +$2.59M | 0.11% | 122 |
|
|
2021
Q1 | $1.09M | Buy |
+5,336
| New | +$1.05M | 0.03% | 564 |
|
|
2020
Q4 | – | Sell |
-11,117
| Closed | -$1.89M | – | 1379 |
|
|
2020
Q3 | $1.86M | Buy |
11,117
+5,986
| +117% | +$1.01M | 0.09% | 170 |
|
|
2020
Q2 | $834K | Buy |
5,131
+4,918
| +2,309% | +$882K | 0.05% | 350 |
|
|
2020
Q1 | $37K | Buy |
+213
| New | +$42.4K | ﹤0.01% | 825 |
|
|
2019
Q2 | – | Sell |
-3,602
| Closed | -$593K | – | 1732 |
|
|
2019
Q1 | $593K | Buy |
3,602
+3,104
| +623% | +$549K | 0.03% | 454 |
|
|
2018
Q4 | $94K | Sell |
498
-24,783
| -98% | -$4.58M | 0.01% | 950 |
|
|
2018
Q3 | $4.3M | Buy |
+25,281
| New | +$4.26M | 0.25% | 64 |
|
|
2018
Q2 | – | Sell |
-1,660
| Closed | -$268K | – | 1697 |
|
|
2018
Q1 | $268K | Buy |
+1,660
| New | +$264K | 0.02% | 612 |
|
|
2017
Q4 | – | Sell |
-517
| Closed | -$70K | – | 1398 |
|
|
2017
Q3 | $70K | Buy |
517
+183
| +55% | +$23.1K | 0.01% | 1004 |
|
|
2017
Q2 | $42K | Sell |
334
-171
| -34% | -$20.5K | ﹤0.01% | 1054 |
|
|
2017
Q1 | $60K | Buy |
+505
| New | +$60.7K | 0.01% | 920 |
|
|
2016
Q4 | – | Sell |
-3,175
| Closed | -$332K | – | 1576 |
|
|
2016
Q3 | $332K | Sell |
3,175
-295
| -9% | -$30.8K | 0.03% | 406 |
|
|
2016
Q2 | $338K | Hold |
3,470
| – | – | 0.05% | 362 |
|
|
2016
Q1 | $333K | Buy |
+3,470
| New | +$316K | 0.05% | 386 |
|
|
2015
Q2 | – | Sell |
-3,625
| Closed | -$343K | – | 1745 |
|
|
2015
Q1 | $343K | Buy |
+3,625
| New | +$336K | 0.05% | 462 |
|
Other funds holding CME
VCM
VPM
Prelude Capital Management's CME Position: Q1 2026 in Review
Prelude Capital Management opened a new position in CME Group (CME) in Q1 2026: 976 shares worth $288K. The stake represents 0.02% of the portfolio and ranks #726 among its holdings. This is a return to the name: Prelude Capital Management previously reported a position in CME as recently as Q2 2025.
Prelude Capital Management first reported a position in CME in Q1 2015 and has held it in 23 quarters since. The position peaked at $4.3M in Q3 2018. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.
- Prelude Capital Management held 976 shares of CME Group worth $288K as of Q1 2026.
- CME Group was a new Prelude Capital Management position in Q1 2026.
- CME Group made up 0.02% of Prelude Capital Management's portfolio in Q1 2026, its #726 holding.
- Prelude Capital Management first reported a position in CME Group in Q1 2015 and has held it in 23 quarters since.
- Prelude Capital Management's CME Group position peaked at $4.3M in Q3 2018.
- 1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.
Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.